Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
Clinical trial NCT00361166 · COMPLETED
Trial details
- NCT number
- NCT00361166
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.